Table 1.
Pooled Patient Demographics (randomized sample)
| Characteristic | Adjunctive Placebo | Adjunctive Aripiprazole |
| Patients, n | 540 | 552a |
| Gender, n (%) | ||
| Male | 181 (33.5) | 174 (31.5) |
| Female | 359 (66.5) | 378 (68.5) |
| Age, mean (SD), y | 44.7 (10.9) | 45.4 (10.8) |
| Race, n (%) | ||
| White | 483 (89.4) | 486 (88.0) |
| Black | 42 (7.8) | 43 (7.8) |
| Asian | 6 (1.1) | 9 (1.6) |
| American Indian/Alaskan native | 2 (0.4) | 2 (0.4) |
| Native Hawaiian/other Pacific Islander | 0 | 3 (0.5) |
| Other | 7 (1.3) | 9 (1.6) |
| Duration of current episode, mo | ||
| Median (range) | 18.8 (1.6–678.8) | 18.8 (1.7–474.1) |
| Single depressive episode, n (%) | 109 (20.2) | 99 (17.9) |
| No. of adequate trials in current episode, n (%) | ||
| 0 | 5 (0.9) | 3 (0.5) |
| 1 | 363 (67.2) | 385 (69.8) |
| 2 | 142 (26.3) | 132 (24.0) |
| 3 | 27 (5.0) | 30 (5.4) |
| ≥4 | 2 (0.4) | 1 (0.2) |
a
Includes 2 subjects who were randomized to aripiprazole treatment in error.